Clinical Trial Update: Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 trial comparing metformin and repaglinide monotherapy for new-onset Type 2 diabetes mellitus in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)
• metformin (metformin)

Snippet

Sponsor: RenJi Hospital | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED